{"symbol":"ABT","fiscalQuarter":"Q3-2018","reportDate":"2018-10-17","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q3-2018","postBrief":{"headline":"Abbott Labs Misses on EPS, Stock Down 1.01%","keyNumbers":[{"metric":"EPS","actual":"$0.75","expected":"N/A","surprise":"-1.29%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized a focus on cost management and operational efficiency."],"summary":"Overall, management expressed concerns about market conditions impacting performance. They reiterated their commitment to navigating these challenges."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs reported earnings that fell short of expectations, resulting in a slight decline in stock price. The lack of revenue data and guidance may leave investors cautious. Management's defensive tone suggests they are facing challenges ahead, which could impact future performance.","metaDescription":"Abbott Labs (ABT) Q3 2018 earnings: EPS missed. Stock down 1.01%. Full breakdown."}}